175 related articles for article (PubMed ID: 37621615)
1. Retracted: New Pyroptosis-Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
Healthcare Engineering JO
J Healthc Eng; 2023; 2023():9809725. PubMed ID: 37621615
[TBL] [Abstract][Full Text] [Related]
2. New Pyroptosis -Associated Gene Signature for Overall Survival Forecast among Patients Suffering from Hepatocellular Carcinoma.
He C; You K
J Healthc Eng; 2022; 2022():6365485. PubMed ID: 35463655
[TBL] [Abstract][Full Text] [Related]
3. Retracted: Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9865740. PubMed ID: 38094394
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
International BR
Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Prediction of Hepatocellular Carcinoma Prognosis and Immune Cell Infiltration Using Gene Signature Associated with Inflammatory Response.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9759467. PubMed ID: 38094384
[TBL] [Abstract][Full Text] [Related]
6. Retracted: Development and Validation of a Novel Mitophagy-Related Gene Prognostic Signature for Hepatocellular Carcinoma Based on Immunoscore Classification of Tumor.
Oncology JO
J Oncol; 2023; 2023():9803262. PubMed ID: 37869587
[TBL] [Abstract][Full Text] [Related]
7. The Pyroptosis-Related Gene Signature Predicts the Prognosis of Hepatocellular Carcinoma.
Zhang S; Li X; Zhang X; Zhang S; Tang C; Kuang W
Front Mol Biosci; 2021; 8():781427. PubMed ID: 35047554
[No Abstract] [Full Text] [Related]
8. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
[TBL] [Abstract][Full Text] [Related]
9. Retracted: A Novel Immune-Associated Gene Signature for Overall Survival Prediction in Patients with Oral Squamous Cell Carcinoma.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9875478. PubMed ID: 38125198
[TBL] [Abstract][Full Text] [Related]
10. A pyroptosis-related gene signature provides an alternative for predicting the prognosis of patients with hepatocellular carcinoma.
Lin D; Chen Z; Zeng Y; Ding Y; Zhao L; Xu Q; Yu F; Song X; Zhu X
BMC Med Genomics; 2023 Jan; 16(1):2. PubMed ID: 36611208
[TBL] [Abstract][Full Text] [Related]
11. A newly identified pyroptosis-related gene signature for predicting prognosis of patients with hepatocellular cancer.
Shen Q; Jiang Y; Hu X; Du Z
Transl Cancer Res; 2022 Sep; 11(9):3175-3186. PubMed ID: 36237236
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic signature of pyroptosis-related genes and relevant characterization in hepatocellular carcinoma.
Wang S; Gao S; Shan L; Qian X; Luan J; Lv X
PeerJ; 2023; 11():e14691. PubMed ID: 36650832
[TBL] [Abstract][Full Text] [Related]
13. Retracted: Identification of Oxidative Stress-Associated Molecular Subtypes and Signature for Predicting Survival Outcome of Cervical Squamous Cell Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9795318. PubMed ID: 37565171
[TBL] [Abstract][Full Text] [Related]
14. Identification of a Pyroptosis-Related Gene Signature for Predicting Overall Survival and Response to Immunotherapy in Hepatocellular Carcinoma.
Zheng S; Xie X; Guo X; Wu Y; Chen G; Chen X; Wang M; Xue T; Zhang B
Front Genet; 2021; 12():789296. PubMed ID: 34925465
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Clinical Value of PPM1G Gene in Survival Prognosis and Immune Infiltration of Hepatocellular Carcinoma.
And Biomechanics AB
Appl Bionics Biomech; 2023; 2023():9862929. PubMed ID: 37946818
[TBL] [Abstract][Full Text] [Related]
16. Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma.
Chen J; Tao Q; Lang Z; Gao Y; Jin Y; Li X; Wang Y; Zhang Y; Yu S; Lv B; Yu Z; Lin C
Oxid Med Cell Longev; 2022; 2022():4494713. PubMed ID: 35069975
[TBL] [Abstract][Full Text] [Related]
17. Retracted: Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
Intelligence And Neuroscience C
Comput Intell Neurosci; 2023; 2023():9817406. PubMed ID: 37564537
[TBL] [Abstract][Full Text] [Related]
18. Retracted: Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Longevity OMAC
Oxid Med Cell Longev; 2023; 2023():9815947. PubMed ID: 37565164
[TBL] [Abstract][Full Text] [Related]
19. Retracted: Prognosis and Therapeutic Efficacy Prediction of Adrenocortical Carcinoma Based on a Necroptosis-Associated Gene Signature.
International BR
Biomed Res Int; 2024; 2024():9850107. PubMed ID: 38550181
[TBL] [Abstract][Full Text] [Related]
20. Identification and validation of a novel pyroptosis-related lncRNAs signature associated with prognosis and immune regulation of hepatocellular carcinoma.
Zhang Z; Xia F; Xu Z; Peng J; Kang F; Li J; Zhang W; Hong Q
Sci Rep; 2022 May; 12(1):8886. PubMed ID: 35614201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
